Overexcited MaxiK and KATP channels underlie obstructive jaundice-induced vasoconstrictor hyporeactivity of arterial

Ya-Wei Yuan1, Long Wang2, Zhan-Ying Lu3

  • 1Department of Anesthesiology, Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.

Scientific Reports
|December 22, 2016
PubMed

Insights

Obstructive jaundice causes vascular hyporesponsiveness by altering MaxiK and KATP channels. Bile duct ligation in rats promoted these channel currents, contributing to vascular dysfunction.

Area of Science:

  • Physiology
  • Vascular Biology
  • Channelopathies

Background:

  • Obstructive jaundice is known to induce vascular hyporesponsiveness.
  • The underlying molecular mechanisms, particularly ion channel involvement, remain incompletely understood.

Purpose of the Study:

  • To investigate the roles of MaxiK (BK) channels and ATP-sensitive potassium (KATP) channels in cholestasis-induced vascular dysfunction.
  • To explore the impact of bile duct ligation (BDL) on vascular reactivity and ion channel function in rat thoracic aorta.

Main Methods:

  • Isolated thoracic aorta from sham-operated and BDL rats were used to assess norepinephrine (NE)-induced contraction.
  • Whole-cell patch clamp recordings were performed on isolated aortic smooth muscle cells to investigate MaxiK and KATP channel function.
  • The expression levels of MaxiK and KATP channel subunits were analyzed.

Main Results:

  • NE-induced vascular contraction was significantly blunted in BDL rats compared to sham controls.
  • Administration of charybdotoxin (MaxiK channel blocker) and glibenclamide (KATP channel blocker) partially restored vascular responsiveness in BDL rats.
  • BDL significantly increased MaxiK and KATP channel currents in aortic smooth muscle cells, with a notable upregulation of auxiliary subunits (MaxiK-β1, SUR2B).

Conclusions:

  • MaxiK and KATP channels are critically involved in the vascular hyporesponsiveness observed in rats with obstructive jaundice.
  • The functional upregulation of these channels, particularly their auxiliary subunits, contributes to cholestasis-induced vascular dysfunction.

Related Concept Videos

Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
2.0K
Autoregulation of Blood Flow01:17

Autoregulation of Blood Flow

Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
8.5K
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.4K
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.9K
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
3.1K
Direct-Acting Cholinergic Agonists: Pharmacological Actions00:59

Direct-Acting Cholinergic Agonists: Pharmacological Actions

Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
2.5K